Smartphones, apps, and biotech all tied together

Smartphones and biotech are not closely related subjects but Nick Paul Taylor, of fiercebiotechit.com, explains that app centers powered by Google, Microsoft, and Blackberry are closing the gap on Apple’s dominance in the app marketplace. Big Pharma and biotech apps traditionally have been exclusive to Apple devices first and then later released to other app stores. But the high growth of Android devices, especially in emerging markets, has forced these apps to be simultaneously released for both devices. Biotech apps have been growing since 2011, and 2013 has not alluded to any signs of this industry slowing down. For the complete article and list of 2013 biotech apps, click here.

Obstacles Facing Biosimilars

Still in its infancy in the U.S., the industry faces some growing pains.

Life Science Accelerated

Pearl Pathways is a comprehensive life science product development services company. Every day we strive to provide our customers top quality service, unyielding ethics, and efficient services through our team of experts. Pearl Pathways supports biopharmaceutical, medical device, and diagnostic companies as well as life science service providers with clinical, regulatory, and quality compliance needs. Our full-service central IRB supports all aspects of human research.